Personalized Lu-177-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: preliminary dosimetry, efficacy and safety results from the P-PRRT trial

M. Del Prete,F. Arsenault, N. Saighi, L. O. Bouchard,A. Beaulieu, F. A. Buteau,J. M. Beauregard

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING(2018)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要